McClellan to think tanks
Executive Summary
Former CMS Administrator Mark McClellan joins the Center for Regulatory Studies, a collaborative program jointly sponsored by the American Enterprise Institute and the Brookings Institution, as a visiting senior fellow. In his joint appointment at the Washington, D.C.-based think tanks, he will work on "the next steps for how I can hopefully continue to have an impact on issues like...the future of Medicare," he says at a Medicare conference sponsored by Avalere in Washington, D.C. Oct. 16. McClellan, who left CMS Oct. 14 after two years as administrator, says he will also continue his academic affiliation with Stanford University. McClellan has been succeeded at CMS by Acting Administrator Leslie Norwalk (1"The Pink Sheet" Sept. 11, 2006, p. 10)...
You may also be interested in...
FDA deputy commissioner resigns
FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb will return to the American Enterprise Institute to work on health policy issues following his resignation from the agency effective Jan. 16. Gottlieb will reunite with Mark McClellan, the former head of FDA and CMS who joined an AEI/Brookings Institution collaborative center last month (1"The Pink Sheet" Oct. 23, 2006, In Brief). Gottlieb served as a senior advisor to McClellan at both agencies...
Next CMS Administrator’s Challenge Will Be Maintaining Part D Momentum
CMS' next administrator will come on board with a key challenge ahead: maintaining Medicare's reputation as a good business partner after initial implementation of the drug benefit, while also satisfying beneficiary advocates and Congress
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.